Mazza Innovation, a manufacturer of bioactive ingredients for the functional food and beverage market, has announced that its Delta, British Columbia, Canada botanical extraction facility is now a Good Manufacturing Practices (GMP) facility registered by NSF International. Earning GMP registration from NSF International verifies that Mazza’s botanical extract production facility has the proper methods, equipment, facilities, and controls in place for producing dietary supplement ingredients at a consistently high level of quality.
NSF’s certification parameters were developed in accordance with the U.S. Food and Drug Administration’s (FDA) 21 CFR part 111 regulations for the manufacturing, packaging, and distribution of dietary supplements. Utilizing GMP guidelines assists companies to develop and maintain proper controls in their manufacturing processes so that products are manufactured and labeled in a consistent manner while meeting quality standards.
“The entire Mazza team is exceptionally pleased to achieve NSF International GMP facility registration that is recognized by the U.S. FDA and throughout the global marketplace,” said Benjamin Lightburn, Mazza Innovation president. “We’ve had an outstanding response from so many potential customers since we opened our new production facility earlier this year, and GMP registration confirms to the marketplace that Mazza has the quality processes to match its exciting innovative technology. We view GMP registration as a significant company milestone.”